Potential Therapeutic Benefits of Strategies Directed to Mitochondria

Overview

Journal Antioxid Redox Signal

Specialty Endocrinology

Date 2009 Dec 17

PMID 20001744

Citations 87

Authors

Amadou K S Camara

Edward J Lesnefsky

David F Stowe

Affiliations

Soon will be listed here.

Abstract

The mitochondrion is the most important organelle in determining continued cell survival and cell death. Mitochondrial dysfunction leads to many human maladies, including cardiovascular diseases, neurodegenerative disease, and cancer. These mitochondria-related pathologies range from early infancy to senescence. The central premise of this review is that if mitochondrial abnormalities contribute to the pathological state, alleviating the mitochondrial dysfunction would contribute to attenuating the severity or progression of the disease. Therefore, this review will examine the role of mitochondria in the etiology and progression of several diseases and explore potential therapeutic benefits of targeting mitochondria in mitigating the disease processes. Indeed, recent advances in mitochondrial biology have led to selective targeting of drugs designed to modulate and manipulate mitochondrial function and genomics for therapeutic benefit. These approaches to treat mitochondrial dysfunction rationally could lead to selective protection of cells in different tissues and various disease states. However, most of these approaches are in their infancy.

Citing Articles

Status of Mitochondrial Oxidative Phosphorylation during the Development of Heart Failure.

Bhullar S, Dhalla N Antioxidants (Basel). 2023; 12(11).

PMID: 38001794 PMC: 10669359. DOI: 10.3390/antiox12111941.

High-fat stimulation induces atrial neural remodeling by reducing NO production via the CRIF1/eNOS/P21 axi.

Zhang A, Li H, Song Q, Cui Y, Zhang Y, Wang X Lipids Health Dis. 2023; 22(1):189.

PMID: 37932729 PMC: 10629039. DOI: 10.1186/s12944-023-01952-7.

Mitochondrial Dysfunction: Pathophysiology and Mitochondria-Targeted Drug Delivery Approaches.

Khan T, Waseem R, Zehra Z, Aiman A, Bhardwaj P, Ansari J Pharmaceutics. 2022; 14(12).

PMID: 36559149 PMC: 9785072. DOI: 10.3390/pharmaceutics14122657.

The Potential of the Mediterranean Diet to Improve Mitochondrial Function in Experimental Models of Obesity and Metabolic Syndrome.

Khalil M, Shanmugam H, Abdallah H, John Britto J, Galerati I, Gomez-Ambrosi J Nutrients. 2022; 14(15).

PMID: 35956289 PMC: 9370259. DOI: 10.3390/nu14153112.

Hypothermia Prevents Cardiac Dysfunction during Acute Ischemia Reperfusion by Maintaining Mitochondrial Bioenergetics and by Promoting Hexokinase II Binding to Mitochondria.

Sun J, Mishra J, Yang M, Stowe D, Heisner J, An J Oxid Med Cell Longev. 2022; 2022:4476448.

PMID: 35873800 PMC: 9301761. DOI: 10.1155/2022/4476448.

References

Rustin P, von Kleist-Retzow J, Chantrel-Groussard K, Sidi D, Munnich A, Rotig A . Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study. Lancet. 1999; 354(9177):477-9. DOI: 10.1016/S0140-6736(99)01341-0. View

Cossu F, Mastrangelo E, Milani M, Sorrentino G, Lecis D, Delia D . Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2. Biochem Biophys Res Commun. 2008; 378(2):162-7. DOI: 10.1016/j.bbrc.2008.10.139. View

Li T, Luo Y, Lu C . [The expression of Smac and XIAP in rat hippocampus following limbic seizure induced by kainic acid injection into amygdaloid nucleus]. Sheng Li Xue Bao. 2004; 56(2):172-7. View

Ridnour L, Oberley T, Oberley L . Tumor suppressive effects of MnSOD overexpression may involve imbalance in peroxide generation versus peroxide removal. Antioxid Redox Signal. 2004; 6(3):501-12. DOI: 10.1089/152308604773934260. View

Bryson J, Coy P, Gottlob K, Hay N, Brooks Robey R . Increased hexokinase activity, of either ectopic or endogenous origin, protects renal epithelial cells against acute oxidant-induced cell death. J Biol Chem. 2001; 277(13):11392-400. DOI: 10.1074/jbc.M110927200. View

Dave K, DeFazio R, Raval A, Torraco A, Saul I, Barrientos A . Ischemic preconditioning targets the respiration of synaptic mitochondria via protein kinase C epsilon. J Neurosci. 2008; 28(16):4172-82. PMC: 2678917. DOI: 10.1523/JNEUROSCI.5471-07.2008. View

Seo B, Marella M, Yagi T, Matsuno-Yagi A . The single subunit NADH dehydrogenase reduces generation of reactive oxygen species from complex I. FEBS Lett. 2006; 580(26):6105-8. DOI: 10.1016/j.febslet.2006.10.008. View

Di Lisa F, Menabo R, Canton M, Petronilli V . The role of mitochondria in the salvage and the injury of the ischemic myocardium. Biochim Biophys Acta. 1998; 1366(1-2):69-78. DOI: 10.1016/s0005-2728(98)00121-2. View

Pasinelli P, Belford M, Lennon N, Bacskai B, Hyman B, Trotti D . Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron. 2004; 43(1):19-30. DOI: 10.1016/j.neuron.2004.06.021. View

10.

Brenner C, Grimm S . The permeability transition pore complex in cancer cell death. Oncogene. 2006; 25(34):4744-56. DOI: 10.1038/sj.onc.1209609. View

11.

Szewczyk A, Skalska J, Glab M, Kulawiak B, Malinska D, Koszela-Piotrowska I . Mitochondrial potassium channels: from pharmacology to function. Biochim Biophys Acta. 2006; 1757(5-6):715-20. DOI: 10.1016/j.bbabio.2006.05.002. View

12.

Martins de Brito O, Scorrano L . Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature. 2008; 456(7222):605-10. DOI: 10.1038/nature07534. View

13.

Di Lisa F, Bernardi P . Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole. Cardiovasc Res. 2006; 70(2):191-9. DOI: 10.1016/j.cardiores.2006.01.016. View

14.

Rappaport L, Oliviero P, Samuel J . Cytoskeleton and mitochondrial morphology and function. Mol Cell Biochem. 1998; 184(1-2):101-5. View

15.

Ho Y, Xiong Y, Ma W, Spector A, Ho D . Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury. J Biol Chem. 2004; 279(31):32804-12. DOI: 10.1074/jbc.M404800200. View

16.

Cassina P, Cassina A, Pehar M, Castellanos R, Gandelman M, de Leon A . Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration: prevention by mitochondrial-targeted antioxidants. J Neurosci. 2008; 28(16):4115-22. PMC: 3844766. DOI: 10.1523/JNEUROSCI.5308-07.2008. View

17.

Schriner S, Linford N, Martin G, Treuting P, Ogburn C, Emond M . Extension of murine life span by overexpression of catalase targeted to mitochondria. Science. 2005; 308(5730):1909-11. DOI: 10.1126/science.1106653. View

18.

Szeto H . Mitochondria-targeted cytoprotective peptides for ischemia-reperfusion injury. Antioxid Redox Signal. 2007; 10(3):601-19. DOI: 10.1089/ars.2007.1892. View

19.

Smith R, Porteous C, Coulter C, Murphy M . Selective targeting of an antioxidant to mitochondria. Eur J Biochem. 1999; 263(3):709-16. DOI: 10.1046/j.1432-1327.1999.00543.x. View

20.

Chinta S, Andersen J . Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson's disease. Free Radic Biol Med. 2006; 41(9):1442-8. DOI: 10.1016/j.freeradbiomed.2006.08.002. View